All
Sarclisa-Containing Treatment Regimen Shows ‘Remarkable’ Results for Relapsed Myeloma
May 17th 2022The combination of Sarclisa, Kyprolis and dexamethasone improved progression-free survival in patients with pretreated, relapsed myeloma, and has potential to become a new standard of care, an expert said.